Sun Pharma Advanced Research Company Limited (BOM:532872)
India flag India · Delayed Price · Currency is INR
134.95
-1.95 (-1.42%)
At close: Feb 12, 2026

BOM:532872 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
-19.6453.35.8412.2493.05
Short-Term Investments
--1,5001,110--
Trading Asset Securities
--18.012,909116.6564.25
Cash & Short-Term Investments
9.419.641,5714,025128.89157.3
Cash Growth
-84.51%-98.75%-60.96%3022.58%-18.06%77.87%
Accounts Receivable
-160.57184.03362.31305.65175.76
Other Receivables
-23.59399.2228.250.260
Receivables
-185.78585.46395.95309.25176.44
Inventory
-19.5414.7910.6610.787.96
Prepaid Expenses
-35.9748.1933.2824.7647.91
Other Current Assets
-1.04474.1185.02237.84241.51
Total Current Assets
-261.972,6944,550711.52631.11
Property, Plant & Equipment
-992.551,0861,073951.18951.08
Other Intangible Assets
-536.53427.12254.68231.166.85
Long-Term Deferred Tax Assets
-23.0912.62---
Other Long-Term Assets
-1,541930.672,424906.97707.86
Total Assets
-3,3555,1508,3012,8012,297
Accounts Payable
-1,1391,4231,483721.87911.68
Accrued Expenses
-228.71374175.93147.37155.73
Short-Term Debt
-1,5824700.51-800
Current Portion of Long-Term Debt
----750380.45
Current Portion of Leases
-37.9934.930.0417.7716.21
Current Income Taxes Payable
-4.4316.47---
Current Unearned Revenue
-408.9800.010.292.7
Other Current Liabilities
-341.2332.29100.4476.9966.74
Total Current Liabilities
-3,7422,6511,7891,7142,334
Long-Term Debt
-1,000---1,125
Long-Term Leases
-69.49106.61126.224.3742.15
Long-Term Unearned Revenue
-625.981,0351,176668.45392.43
Pension & Post-Retirement Benefits
-22.42-11.3218.8229.22
Other Long-Term Liabilities
-64.52100.7470.0662.6557.1
Total Liabilities
-5,5253,8933,1742,4893,979
Common Stock
-324.53324.53324.53271.89262.06
Additional Paid-In Capital
-20,38220,38220,38211,0649,405
Retained Earnings
--22,876-19,449-15,578-13,366-11,349
Comprehensive Income & Other
-0.680.07-2,343-
Shareholders' Equity
-3,446-2,1691,2585,128312.26-1,683
Total Liabilities & Equity
-3,3555,1508,3012,8012,297
Total Debt
4,1662,689611.51156.75792.142,364
Net Cash (Debt)
-4,157-2,670959.83,868-663.25-2,207
Net Cash Growth
---75.19%---
Net Cash Per Share
-12.81-8.232.9613.59-2.52-8.42
Filing Date Shares Outstanding
324.27324.52324.52324.52271.88262.05
Total Common Shares Outstanding
324.27324.52324.52324.52271.88262.05
Working Capital
--3,48043.282,760-1,003-1,702
Book Value Per Share
-10.63-6.693.8815.801.15-6.42
Tangible Book Value
-4,160-2,706830.444,87381.1-1,689
Tangible Book Value Per Share
-12.83-8.342.5615.020.30-6.45
Land
-80.3580.3580.3580.3580.35
Buildings
-310.4308.55303.62300.07273.69
Machinery
-1,000993.88887.9854.83774.81
Construction In Progress
-5.6112.6918.7337.252.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.